The Phoenix Trial: Phase II Trial of Cemiplimab for the Non-operative Management of Localized dMMR Colon Cancer (NCT05961709)

🧪 Interventions in This Study

• Cemiplimab (DRUG)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (5 Sites)

• Banner - MD Anderson Cancer — Gilbert, Arizona
• Baptist - MD Anderson Cancer Center — Jacksonville, Florida
• Ochsner — New Orleans, Louisiana
• Cooper University Medical Center — Camden, New Jersey
• M D Anderson Cancer Center — Houston, Texas

📞 Contact the Study Coordinator

Phone: (877) 632-6789

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Colon Cancer

• CEND-1 in Combination with Neoadjuvant FOLFIRINOX with or Without Panitumumab — Fairway, Kansas
• A Study of Imaging, Blood, and Tissue Samples to Guide Treatment of Colon Cancer and Related Liver Tumors — Basking Ridge, New Jersey
• Voyage: Real-World Impact of the Multi-target Stool DNA Test on CRC Screening and Mortality — Rochester, Minnesota
• The Exercise And Colorectal Cancer Treatment Trial — Baton Rouge, Louisiana
• Fiber-rich Foods to Treat Obesity and Prevent Colon Cancer — Atlanta, Georgia

Explore by condition: All Colon Cancer clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Contact the study coordinator using the phone/email above.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.